RATIONAL USE OF ANTIBIOTICS
EXPERT COMMITTEE ON RATIONAL USE OF ANTIBIOTICS
Chairman: V K E Lim
Members: O P Foo, R Jalleh, P Kandasami, E L Lee, J Mohan, T S Ng, S Rahman, T Essau
Contents
GENERAL PRINCIPLES
IN THE USE OF ANTIBIOTIC
Introduction
Monitoring
efficacy
ANTIBIOTICS
GUIDELINES 1996
2.1 Guidelines on antibiotic therapy
Table 1. Respiratory Infections
Table 2. Urinary Tract Infections
Table 3. Skin and Soft Tissue Infections
Table 4. Musculosketel Infections
Table 5. Gastrointestinal Infections
Table 6. Genitourinary Infections (Including Sexually Transmitted Diseases)
Table 7. Central Nervous System Infections
Table 8. Cardiovascular Infections
Table 9. Bacteraemia And Septicaemia
Table 10. Other Infections
Table 11. Infections Associated With Pregnancy
Table 12. Chemoprophylaxis For Selected Medical Condition
PARENTERAL ANTIBIOTIC DOSAGES FOR SERIOUS INFECTIONS IN INFANTS AND CHILDREN
ANTIBIOTIC DOSAGES OF ORAL ANTIBIOTICS FOR INFANTS AND CHILDREN
GENERAL PRINCIPLES IN THE USE OF
ANTIBIOTICS
Introduction
Antibiotics are one of the most commonly prescribed drugs today. Rational use of
antibiotics is extremely important as injudicious use can adversely affect the patient,
cause emergence of antibiotic resistance and increase the cost of health care. Prescribing
an antibiotic comprises several phases:
i) perception of need - is an antibiotic necessary ?
ii) choice of antibiotic - what is the most appropriate antibiotic ?
iii) choice of regimen : what dose, route, frequency and duration are needed ?
iv) monitoring efficacy : is the treatment effective ?
Is an antibiotic necessary?
Antibiotics are generally only useful for the treatment
of bacterial infections. It is important to remember that not all fevers are due to
infections and not all infections are caused by bacteria. The majority of infections seen
in general practice are of viral origin and antibiotics can neither treat viral infections
nor prevent secondary bacterial infections in these patients. Even where a bacterial
aetiology is established, an antibiotic may not be always necessary. Many bacterial
infections resolve spontaneously. Minor superficial skin infections may be more suitably
treated with a local antiseptic. Collections of pus should be drained surgically and if
drainage is adequate, antibiotics are often not required.
Choice of an antibiotic
The successful outcome of therapy would depend very much on the choice of the
antibacterial agent. In the process of selecting an antibiotic, three main factors need to
be considered; the aetiological agent, the patient and the antibiotic.
The aetiological agent
Determination of the aetiological agent depends on a combination of clinical acumen and
laboratory support. In many instances an antibiotic prescription has to be made based on
the clinical diagnosis (empirical therapy). Even where a bacteriology report is available
it is necessary to interpret the report. Bacterial isolates from culture specimens may
represent normal flora, colonisers or contaminants rather than true pathogens. Sensitivity
results when available are at best only a guide to treatment. Laboratory reports should
always be viewed in the light of clinical findings.
The patient
Several patient factors have to be considered in selecting an antibiotic. Age is an
important factor. The very young and the very old tend to be more prone to the adverse
effects of the antibiotics. Neonates have immature liver and renal functions which affect
their ability to metabolise or excrete antibiotics. Antibiotics and their metabolites may
adversely affect growing tissues and organs in children. Elderly patients are more likely
to suffer from nephrotoxicity and allergic reactions. Dosage modifications would also have
to be made in those patients with hepatic or renal impairment. Antibiotics can also give
rise to severe toxic reactions in patients with certain genetic abnormalities eg
sulphonamides in patients with glucose-6-phosphate dehydrogenase deficiency. Antibiotics
should as far as possible be avoided in pregnancy and when it is necessary to use an
antibiotic, betalactam antibiotics and erythromycin are probably the safest. A history of
allergy to antibiotics should always be sought before administration. Routine intradermal
test doses for penicillin allergy is of little value and may even be dangerous. If in
doubt avoid betalactams and use a macrolide or tetracycline (in adults) instead. In
serious infections like meningitis and bacteraemic shock the immediate institution of the
best available antibiotic for the suspected pathogen(s) is imperative as delay in
treatment will increase both mortality and morbidity. In less serious situations such as
otitis media where spontaneous recovery is common, an antibiotic that covers for the
predominant organisms is adequate.
The antibiotic
The clinician should have adequate knowledge of the pharmacokinetic properties of the
antibiotic he uses. Antibiotics vary in their ability to be absorbed orally or to cross
the blood brain barrier and these factors will affect their routes of administration. The
ability of the antibiotic to achieve therapeutic concentrations at the site of infection
is another important consideration thus antibiotics used for treating urinary infections
should ideally be concentrated in urine. Some antibiotics have very severe toxic effects
and are best avoided in certain conditions. The doctor should also be aware of drug-drug
interactions since many antibiotics can interact with other non-antibiotic drugs. Finally
the cost of the antibiotic is also of major concern. In calculating costs it is perhaps
more reasonable to take into account the total cost of treatment rather than just the
actual cost of antibiotic per dose. The route of administration, the necessity for
monitoring antibiotic levels and the patient's length of stay in hospital can affect the
cost of treatment as well. The patient's compliance to medication is an important factor
for consideration in the choice of antibiotics.
Choice of regimen
Parenteral or oral
Whether the route of administration should be oral or parenteral would depend on whether
the patient is able to take oral treatment reliably. In cases of severe sepsis where
rigors, hyperthermia/hypothermia, tachycardia and hypotension are present, intravenous
therapy should be instituted. When in doubt it would be safer to commence intravenous
treatment and review the treatment daily.
Duration of treatment
Except for a few conditions, the optimum duration of antibiotic treatment is unknown. Many
antibiotics are often presribed for a duration of 5-7 days. Nevertheless it is reasonable
to discontinue therapy even after a shorter period if the patient's symptoms have
resolved. There are however certain infections where prolonged treatment is necessary
(Table I). In some conditions eg uncomplicated cystitis in women and gonococcal urethritis
in males, single dose regimens have been shown to be effective.
Table I. Conditions where a minimum duration of treatment has been established.
Infection |
Minimum duration of treatment |
| Tuberculosis | 4 -6 months |
| Empyema and lung abscess | 4 - 6 weeks |
| Endocarditis | 4 weeks |
| Osteomyelitis | 4 weeks |
| Atypical pneumonia | 2 - 3 weeks |
| Pneumococcal meningitis | 7 days |
| Pneumococcal pneumonia | 5 days |
Monitoring efficacy
Early review of response
A routine early review ( 3 days after commencing treatment) of the patient's response is
important in order to ensure that the patient is receiving appropriate treatment. After
review the doctor will have to decide whether to:
i) continue with the present regimen
ii) increase the level of treatment by changing from oral to parenteral; increasing the
dose or
changing to a broader spectrum antibiotic
iii) decrease the level of treatment by changing from parenteral to oral, decreasing the
dose or
changing to a more specific narrow spectrum antibiotic
iv) stopping the antibiotic if the infection has resolved; the objective of treatment is
achieved or
the diagnosis has been changed.
Inconsistent microbiology reports
If the patient is responding there is no necessity to change antibiotic even when the
laboratory reports a resistant organism. The isolate in question could have been a
coloniser or a contaminant. Infections may resolve spontaneously and the antibiotic could
have affected the bacteria in a way that makes it more susceptible to the host's immune
defenses.
If the patient's condition fails to improve, a change in
antibiotic may be necessary even when the laboratory reports a sensitive organism.
Causes of non-response to antibiotics
A patient may fail to respond to an antibiotic for a number of reasons which include:
i) the aetiological agent is resistant to the antibiotic
ii) the diagnosis is incorrect
iii) the choice of antibiotic is correct but the dose and/or route of administration is
wrong
iv) the antibiotic cannot reach the site of infection
v) there is a colletion of pus that should be drained surgically or a foreign
body/devitalised
tissue that should be removed
vi) there is secondary infection
vii) antibiotic fever
viii) non-compliance of the host
Changing from intravenous to oral
Wherever feasible intravenous therapy should be changed to oral therapy. The oral
antibiotic (not necessarily the oral preparation of the intravenous antibiotic) should be
selected based on clinical and laboratory findings. Similarly one should not hesitate to
revert to intravenous therapy if the patient's condition warrants it.
References:
1. Kass E H. Antimicrobial drug usage in general
hospitals in Pennsylvania. Ann Int
Med 1976; 89 : 802 - 805.
2. Lim V K E, Cheong Y M and Suleiman A B. Pattern of antibiotic usage in hospitals
in Malaysia. Singapore Med J 1993; 34 : 525 - 528.
3. Ackerman V P, Pritchard R C, Groot Obink D J, Bradbury R and Lee A.
Consumer survey on microbiology reports. Lancet 1979; i : 199 - 203.
4. Cooke D, Salter A J and Phillips I. Antibiotic misuse, antibiotic policies and
information resources. J Antimicrob Chemother 1980; 6 : 435 -
443.
5. Obaseiki-Ebor E E, Akerele J O and Ebea P O. A survey of outpatient prescribing
and antibiotic self medication. J Antimicrob Chemother 1987; 20 : 759
-763.
6. Aswapokee N, Vithayapichet S and Heller R F. Pattern of antibiotic use in medical
wards of a University Hospital, Bangkok, Thailand. Rev Infect Dis 1990;
12 : 136 -
141.
7. Cheong YM, Lim VKE, Jegathesan M and Suleiman AB. Med J Malaysia 1994; 47
:
8. Kunin C M, Lipton H L, Tupasi T, Sacks T, Scheckler W E, Jivani A, Goic A,
Martin R R, Guerrant R L and Thamlikitkul V. Social, behavioural
and practical
factors affecting antibiotic use worldwide: Report of task force 4. Rev
Infect Dis
1987; 9 (Suppl 1) : S270 - S285.
9. Fourth Western Pacific Congress on Chemotherapy and Infectious Diseases.
Consensus statement on policies and strategies for promoting
appropriate antibiotic
use. Manila, 1994.
8. Williams J D. Antibiotic policy. Scan J Infect Dis 1986; Supplement 49 : 175 -181
ANTIBIOTIC GUIDELINES 1996
GUIDELINES ON ANTIBIOTIC THERAPY
The following guidelines are issued for the more common infections only. However even for common infections they may not apply to certain patients. When in doubt always seek a second opinion. The recommendations for first and second choice regimens are based on a global assessment of efficacy, adverse effects , prevailing sensitivity patterns and cost. It should also be noted that guidelines such as these have to be reviewed and updated from time to time.
NOTE :
1. Erythromycin may be substituted for by a newer
macrolide.
2. Gentamicin may be substituted for by another aminoglycoside depending on the
local prevailing sensitivity pattern.
3. Where ampicillin is recommended amoxycillin may also be used.
Ampicillin/amoxycillin may be substituted for by a
betalactam/betalactamase
inhibitor combination depending on the local prevailing sensitivity
pattern.
4. Cloxacillin is the drug of choice for severe methicillin-sensitive Staphylococcus
aureus. For oral therapy flucloxacillin is preferred to
cloxacillin as the former is
more reliably absorbed and achieves higher tissue levels. In some
children who
cannot tolerate cloxacillin a first or second generation cephalsoporin
may be used.
5. Quinolones are not recommended in children.
Abbreviations:
1o : First generation
2o : Second generation
3o : Third generation
Table 1. RESPIRATORY INFECTIONS
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Acute
pharyngitis/tonsillitis, scarlet fever (Streptococcus pyogenes suspected or proven) |
Penicillin V | Erythromycin | The majority of sore throats are viral in origin and antibiotics are not indicated for treatment or prevention of secondary bacterial infections. |
| Diphtheria (Corynebacterium diphtheriae) |
Benzylpenicillin | Antibiotics are not the
mainstay of treatment. Antitoxin and supportive treatment are critical in
management. Close contacts should receive erythromycin. Non-immunised contacts should be immunised. |
|
| Acute otitis media and acute
sinusitis (Strep pneumoniae, Haemophilus influenzae & Moraxella catarrhalis) |
Ampicillin or Betalactam/ betalactamase inhibitor combination |
New macrolides | Most strains of Strep pneumoniae and Haemophilus influenzae in Malaysia are sensitive to ampicillin. However many strains of Moraxella catarrhalis are resistant to ampicillin. |
| Acute epiglottitis
(Haemophilus influenzae) |
Chloramphe-nicol | Ampicillin or 3o cephalo-sporin |
Acute epiglottitis is a medical emergency and hospitalisation with aggressive therapy is required |
| Pertussis (Bordetella pertussis) |
Erythromycin | Antibiotic treatment does not significantly alter the course of disease. If given early it helps to eradicate oropharyngeal organisms thus interrupting transmission. |
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Acute bronchitis ( 2o bacterial infections due to Streptococcus pneumoniae & Hae-mophilus influenzae) |
Ampicillin | Erythromycin or Doxycycline (adults only) |
Acute bronchitis is primarily a
viral infection and antibiotics are not indicated. However 2o bacterial infection
may occur in severe cases. Erythromycin is preferred if Mycoplasma is suspected on epidemiological or other grounds. |
| Acute exacerbations of
chronic bronchitis (Streptococcus pneumoniae, Hae-mophilus influenzae, Moraxella catarrhalis) |
Ampicillin or Betalactam/ betalacta-mase inhibitor combination |
Erythromycin or Doxycycline (adults only) |
|
| Acute bronchial asthma | Antibiotics are not indicated | There is no evidence that antibiotics will significantly alter outcome. | |
| Pneumonia Community acquired pneumonia - mild to moderate (Streptococcus pneumoniae, Hae-mophilus influenzae, Mycoplasma) Community acquired pneumonia - severe |
Benzylpenicillin or Ampicillin or Erythromycin Benzylpenicillin and |
Betalactam/ |
Erythromycin is preferred when Mycoplasma
is suspected. When Staph aureus is suspected or demonstrated use cloxacillin and gentamicin. |
| Atypical pneumonia
(Mycoplasma pneu-moniae, chlamydia, Legionella) |
Erythromycin or Doxycycline (for adults) |
||
| Chlamydia trachomatis penumonia in infancy | Erythromycin | Transmitted from mother. Usually becomes clinically apparent 2 - 20 weeks after birth. |
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Nosocomial pneumonia
Post-operative/coma severe cases where MRSA is demonstrated or strongly suspected ventilated patients immunosuppressed |
Benzylpenicillin and
Gentamicin |
If vancomycin is not available a combination of
fucidin and rifampicin may be used Pneumonia in the immunocompromised may also be caused by a variety of non-bacterial agents eg fungi (Candida, Aspergillus ), Toxoplasma, Pneumocystis and viruses.
|
|
| Lung abscess/ empyema
(mixed infection of anaerobes, Staphylococcus aureus, Streptococcus pneumoniae and aerobic gram negative bacilli) |
Benzylpenicillin and |
Empyema in childhood is nearly always due to staphylococci. Where staphylococci is suspected substitute cloxacillin for benzyl penicillin |
Table 2. URINARY TRACT INFECTIONS
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Acute urinary tract
infection (E. coli, Staphylococcus saprophyticus) |
Cotrimoxa-zole or Trimethoprim or Ampicillin or Nitrofurantoin |
1o/2o cephalo-sporin | Many hospital acquired
pathogens are now resistant to ampicillin. In uncomplicated cystitis in adults 4 tabs cotrimoxazole in a single dose has been shown to be effective. In pregnancy ampicillin should be given for 10 days |
| Pyelonephritis and
complicated urinary tract infection (E. coli, other Enterobacteriaceae) |
2o Cephalo-sporin and Gentamicin or a quinolone |
In all cases an attempt should be made to exclude any underlying abnormality | |
| Recurrent urinary infection
(E. coli, other Enterobacteriaceae, enterococci) |
Cotrimoxazole 1 tab nightly or Nitrofurantoin 50 mg nightly |
Ampicillin 500 mg nightly or Cephalexin 250 mg nightly or Nalidixic acid 500 mg nightly |
Recurrent urinary tract
infections may require very prolonged prophylaxis. Female patients should be advised on perineal hygiene and micturition after intercourse. Treat current infection before starting on prophylaxis. Cotrimoxazole should be avoided during the 3rd trimester of pregnancy. |
| Catheter associated
infections (Enterobacteriaceae, Pseudomonas and Enterococcus) |
Treat accord-ing to culture & sensitivity report | Isolation of bacteria in urine
culture per se is not an indication while catheter is in-situ. Antibiotics will not
eradicate the bacteria and may promote resistance instead. Treatment is only necessary is systemic signs are present and based on the most recent culture. Catheter care is all important. Bladder irrigation is generally not useful and may introduce infection. The catheter should be removed as early as it is possible. If the catheter is changed in the presence of bacteriuria, a single prophylactic dose of antibiotic should be given 30 minutes before the procedure. |
|
| Acute urinary infection in
children (E. coli and other Enterobacteriaceae) Mild
|
2o/3o cephalosporin |
In all cases assessment of
renal function (cystograms, ultrasound of kidneys, ureters and bladder) should be
performed. Prophylactic antibiotics for children < 4 years is recommended in cases where anatomical abnormalities are detected. |
Table 3. SKIN AND SOFT TISSUE INFECTIONS
| Condition | 1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Impetigo (Strep pyogenes, Staph aureus) |
Penicillin | Erythromycin or Cloxacillin and Penicillin or Cephalexin |
Mupirocin ointment may be considered for topical use in cases of MRSA infections. |
| Boils and carbuncles
(Staph aureus) |
Erythromycin | Cloxacillin or Cephalexin |
Surgical drainage is the definitive mode of treatment and antibiotics may not be necessary if drainage is adequate. |
| Cellulitis/Erysipelas/
Lymphangitis (Strep pyogenes) Severe cases
Mild to moderate cases |
Benzylpenicillin or Procaine penicillin Penicillin V 2o or 3o Ceph-alosporin |
|
Change to oral therapy once patient's condition improves. |
| Decubitus ulcers (Enterobacteriaceae, Pseudomonas, Enterococcus, anaerobic bacteria) |
Antibioticsare not indicated unless systemic symptoms are present. | 2o Cephalosporin and Metronidazole may be used in cases with systemic symptoms | |
| Diabetic foot infections
(Polymicrobial infection - Enterobacteriaceae, Staph aureus, streptococci, anaerobic bacteria) |
2o or 3o
Cephalo-sporin and Metronida-zole or Betalactam-betalacta-mase inhibitor combination |
Cloxacillin and Gentamicin and Metronida-zole |
Diabetic foot infections may
involve extensive tissue and bone necrosis. Surgical debridement is often necessary. The duration of treatment depends on the response. |
| Infected bites (animal bites : Pastuerella multocida, staphylococci human bites : mouth flora) |
Ampicillin and/or Cloxacillin |
Erythromycin | Tetanus toxoid should be
administered to patients requiring a booster. The value of antibiotic prophylaxis in clinically uninfected bites is not proven. For hand wounds and extensive injuries a 5 day course of antibiotics is advised. Human bites may have medicolegal implications and proper documentation including photographs may be necessary. |
| Umbilical sepsis | Antibiotics are generally not
indicated. Where there is evidence of spread a course of cloxacillin is recommended. |
||
| Lymphadenitis (Staph aureus, Strep pyogenes) |
Cloxacillin or Erythromycin or 1oCephalosporin |
Table 4. MUSCULOSKELETAL INFECTIONS
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Acute osteomyelitis
(Staph aureus - commonest; others include Enterobacteriaceae, Pseudomonas) In children < 5 yr staphylococci, streptococci and Haem influenzae |
Cloxacillin | Fusidic acid | For children < 5 yr use a
combination of cloxacillin and 2o/ 3o Ceph-alosporin
|
| Chronic osteomyelitis
(Staph aureus, Enterobacteriaceae, Pseud aeruginosa) |
Cloxacillin | Fucidic acid and Rifampicin or according to culture report |
Where MRSA is suspected or
proven, fucidic acid and rifampicin should be 1st choice antibiotics. For cases due to Pseud aeruginosa, an antipseudomonal fluroquinolone may be considered. |
| Septic arthritis ( > 5 years : Staph aureus; < 5 years : Staph aureus, Haem influenzae) |
Cloxacillin | For children < 5 yr use a
combination of cloxacillin and 2o/ 3o Ceph-alosporin
|
|
| Compound fractures
(Staph aureus, gram negative bacilli) Grade I fractures
Grade II fractures
Grade III fractures |
2o or 3o Ceph-alosporin 2o or 3o Ceph-alosporin Gentamicin |
The optimum duration of
antibiotic administration has not been established. No differences have been shown in 1,3
or 5 day courses. Infection is more likely in Grade 3 fractures with severe soft tissue and vascular injuries. Routine cultures should be taken and the antibiotics changed if necessary. This especially so for cases where surgery is delayed. Early surgical debridement and adequate fracture stabilisation within 6-8 hours of injury is the most important aspect of treatment. |
|
| Gas gangrene (Clostridium sp) |
Benzylpenicillin | Use 4 mega 6 hrly |
Table 5. GASTROINTESTINAL INFECTIONS
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Gingivitis (Spirochaetal organisms, streptococci and oral anaerobes) |
Penicillin V and Metronida-zole |
||
| Periodontal infections
(Streptococci and oral anaerobes) |
Penicillin V | Erythromycin | |
| Oral thrush (Candida albicans and other candida species) |
Syrup Nystatin | Azole (oral gel) | |
| Acute cholecystitis
(Enterobacteriaceae, Enterococcus and Bacteroides) |
2o or 3o Ceph-alosporin with or without Metronidazole |
Gentamicin with or without Metronidazole |
|
| Acute cholangitis (Enterobacteriaceae, Bacteroides) |
Ampicillin or 2o or 3o Ceph-alosporin |
Gentamicin | |
| Acute peritonitis Primary (children) (Strep pneumoniae, other streptococci, staphylococci, Enterobacteriaceae) Primary (adults with cirrhosis) (Enterobacteriaceae) Secondary
|
Penicillin and gentamicin
|
3o Ceph-alosporin
Gentamicin
|
|
| Antibiotic associated
colitis (Clostridium difficile) |
Vancomycin (oral) or Metronidazole |
||
| Enteric fever (Salmonella typhi, Salmonella paratyphi) |
Chloramphe-nicol or Cotrimoxazole or Ceftriaxone |
Ampicillin or Quinolone |
The majority of strains of Salmonella
typhi isolated in Malaysia are still sensitive to chloramphenicol. The newer fluoroquinolones have been shown to be effective for the treatment of carriers. |
| Acute uncomplicated
diarrhoeas (viruses, E. coli, Salmonella sp, Shigella sp, Campylobacter) |
No antibiotic necessary | Oral rehydration salt solutions (ORS) should be given for replacement therapy. Salmonella sepsis is not uncommon in severely ill infants and a 3o cephalosporin is indicated when suspected. |
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Cholera ( Vibrio cholerae O1, O139) |
Doxycycline for 4 days | Replacement of fluids and
correction of electrolyte imbalances are the mainstay of treatment. Use syrup tetracycline in children. |
|
| Bacterial dysentery
(Shigella, Salmonella, enteroinvasive E. coli) |
Cotrimoxazole (Only in severe dysentery) | Shigella in Malaysia is often resistant to multiple antibiotics. For such strains the use of a quinolone may be considered. | |
| Amoebic dysentery (Entamoeba histolytica) |
Metronidazole | Tinidazole | |
| Liver abscess Pyogenic (coliforms, staphylococci, micro-aerophilic streptococci) Amoebic |
Ampicillin and Metronida-zole
Metronida-zole |
2o or 3o ceph-alosporin and Metronida-zole Tinidazole |
Table 6.
GENITOURINARY INFECTIONS (INCLUDING SEXUALLY TRANSMITTED DISEASES)
Note : For all sexually transmitted diseases every effort should be made for contact
tracing and treatment of the sexual partners.
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Pelvic inflammatory disease
(anaerobic bacteria, streptococci, Entero-bacteriaceae, chlamydia, Neisseria gonorrhoeae) Mild to moderate
Severe |
Doxycycline Doxycycline |
||
| Vaginitis Candidal (Candida albicans, Candida tropicalis, other Candida spp) Bacterial vaginosis |
Nystatin
Metronida-zole Metronida-zole |
Fluconazole
Ampicillin |
|
| Gonorrhoea (Neisseria gonorrhoeae) Uncomplicated urethritis, rectal and pharyngeal gonorrhoea Adult gonococcal ophthalmia
|
Spectino-mycin
Spectino-mycin Ceftriaxone |
For uncomplicated urethritis, rectal and pharyngeal gonorrhoea single dose treatment is sufficient.
In gonococcal ophthalmia parenteral antibiotics should be accompanied by hourly conjunctival irrigation with saline or antibiotic eyedrops. |
|
| Non-gonococcal urethritis
(Chlamydia tra-chomatis, Ureaplasma urealyticum) |
Doxycycline or Erythromycin
|
Doxycycline or erythromycin
should be given for at least seven days. With certain newer macrolides single dose regimens have been shown to be effective. |
|
| Inclusion conjunctivitis
(adults) (Chlamydia tra-chomatis) |
Doxycycline or Erythromycin |
Duration of treatment should be fourteen days. | |
| Syphilis (Treponema pallidum) Early
|
Procaine penicillin (10 days) or Procaine Procaine or Benzyl pencillin (21 days) Benzyl-penicillin |
For patients allergic to
penicillin
Erythromycin or doxycycline for 30 days
Doxycycline for 30 days Asymptomatic babies born of syphilitic mothers should also be treated |
|
| Chancroid (Haemophilus ducreyi) |
Cotrimoxazole or Ceftriaxone |
Bubos should be aspirated, not incised and drained. |
Table 7. CENTRAL NERVOUS SYSTEM INFECTIONS
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Meningitis (Haemophilus
influen-zae, Streptococcus pneumoniae, Neisseria meningitidis) Adult
|
Ampicillin and Ampicillin and gentamicin |
When the pathogen is known the
antibiotic of choice for pneumococcal and meningococcal meningitis is benzyle penicillin.
For haemophilus meningitis chloramphenicol or a 3o cephalosporin is the drug of
choice. Meningitis caused by penicillin resistant pneumococci and ampicillin/chloram-phenicol resistant haemophilus are still uncommon in Malaysia. Many laboratories have rapid diagnostic kits and results can often be obtained within a few hours.
|
|
| Cryptococcal
meningitis (Cryptococcus neoform-ans) |
Amphotericin B and 5 Flu-cytosine | Fluconazole may be considered as an alternative drug for cryptococcal meningitis. | |
| Brain abscess (adults)
( Streptococci, anaerobic organisms) Brain
abscess (children) |
Benzylpenicillin and Metronidazole Cloxacillin |
3o Cephalo-sporin and Metronidazole |
Surgical drainange is the definitive treatment for brain abscess. |
Table 8. CARDIOVASCULAR INFECTIONS
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Endocarditis Non-intravenous drug user (Streptococcus viridans group) Intravenous
drug user
Post-surgical endocarditis |
Benzylpenicillin and Gentamicin
Cloxacillin
Cloxacillin |
Dosage: Penicillin 2-3 mega iv, 4-6 hrly for 4-6 weeks Gentamicin 1.0 mg/kg iv, 8 hrly for 2-6 weeks Cloxacillin 2 g iv, 4hrly for 6 weeks. After 4 weeks of iv penicillin, replacement with oral penicillin plus probenecid can be considered. When endocarditis is shown to be due to Enterococcus use ampicillin 2 g iv 6hrly and gentamicin for 6 weeks. Endocarditis in IDUs often involves the tricuspid valves and associated with pneumonia/lung abscess. Endocarditis in IDUs may occasionally be caused by gram negative bacilli in which case treatment should be based on the sensitivity report. For MRSA infections use vancomycin or a combination of fucidic acid and rifampicin. Staphylococcus epidermidis is often resistant to cloxacillin thus vancomycin may have to be used instead. Other bacteria and fungi can also cause post-surgical endocarditis and treatment will be according to culture report. Surgical intervention is often necessary for prosthetic valve infection. |
Table 9. BACTERAEMIA AND SEPTICAEMIA
Condition (According to most likely focus |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Urinary (community acquired
- Enterobact-eriaceae, Enterococcus) Urinary (hospital acquired - Pseudomonas and other gram negative aerobic bacilli) |
Ampicillin and Gentamicin 2o or 3o generation Cephalo-sporin |
||
| Gall bladder/bowel
(Enterobacteriaceae, Enterococcus, anaerobic organisms) |
3ogeneration
Cephalo-sporin and Metronida-zole |
Gentamicin and Metronida-zole or Betalactam-betalactamse inhibitor combination and gentamicin |
|
| Female pelvis (Enterobacteriaceae, Enterococcus, anaerobic organisms) |
Gentamicin and Metronida-zole |
2o or 3o generation
Cephalo-sporin and Metronida-zole |
|
| Skin (cellulitis) (Streptococcus pyogenes) Skin
(abscess) Decubitus ulcers, diabetic foot ulcers |
Benzylpenicillin Cloxacillin
Cloxacillin |
Betalactam-betalactamse inhibitor combination and gentamicin |
|
| Intravascular lines
(Staphylococci, Enterobacteriaceae) |
Cloxacillin and Gentamicin |
The infected line should be
removed. Where MRSA and MRSE are prevalent use vancomycin or a combination of fucidic acid and rifampicin. |
|
| Lung - community acquired
(Staphylococcus aureus) Lung - hospital acquired (Staphylococcus aureus, aerobic gram negative bacilli) |
Cloxacillin and Gentamicin |
3o generation Cephalo-sporin |
|
Condition (According to most likely focus |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Neutropaenic | 3o generation Cephalosporin
and Gentamicin |
Ureidopeni-cillin or carbapenem and Gentamicin
|
In a significant proportion of
neutropaenic patients cultures are negative. Many authorities would recommend commencement of antifungal treatment if there is no response after 3 - 5 days of antibacterial treatment. |
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Scrub typhus (Rickettsia tsutsugamushi) |
Tetracycline (to be given until
at least 48 hours after fever has subsided) or Doxycycline for 3 days |
If treatment is initiated before the fifth day of clinical disease, a further 3 day course 4 days later is required to prevent relapse. | |
| Melioidosis (Burkholderia pseudomallei) |
Ceftazidime for 14-21
days followed by Doxycycline or Cotrimoxazole or Amoxycillin/clav-ulanic acid for 3 months |
Treatment for longer than 3 months may be necessary for some cases |
Table 11.
INFECTIONS ASSOCIATED WITH PREGNANCY
Antibiotics should be used with care in pregnancy. Beta-lactam antibiotics and macrolides
are probably the safest antibiotics to use in pregnancy.
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Asymptomatic bacteriuria/
Cystitis ( E. coli ) |
Ampicillin or Cephalexin |
||
| Acute pyelonephritis
( E. coli ) |
2o or 3o generation Cephalo-sporin | Ampicillin | |
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Chorioamnionitis/ Prolonged rupture of membranes (Group B streptococci, anaerobes, Enterobacteriaceae) |
2o or 3o generation
Cephalosporin and Metronidazole |
Ampicillin and Gentamicin and Metronidazole |
|
| Puerperial and post-abortal
sepsis (Streptococci, Entero-coccus, staphylococci, Enterobacteriaceae, anaerobes) |
2o or 3o generation
Cephalosporin and Metronidazole |
Ampicillin and Gentamicin and Metronidazole |
Table12. CHEMOPROPHYLAXIS FOR SELECTED MEDICAL CONDITIONS
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Rheumatic fever | Benzathine penicillin 1.2 mega every 4 weeks | Penicillin V 250 mg 12 hrly or Erythromycin 250 mg 12 hrly |
Prophylaxis should be maintained for many years. Children should continue to receive prophylaxis until the age of 25 years and adults for at least 5 years whichever is the longer. |
| Cholera | Tetracycline 1 g daily for 5 days or Doxycycline 200 mg stat dose |
Condition |
1st Choice antibiotic(s) |
2nd Choice antibiotic(s) |
Notes |
| Bacterial endocarditis
For dental and upper respiratory procedures
For patients who have prosthetic valves or previous endocarditis undergoing dental and upper respiratory procedures; and for patients undergoing genitourinary manipulation
For patients with prosthetic valves undergoing cardiac catheterisation, pace-maker insertion and skin biopsy |
Amoxycillin 3 g oral 1 hour
before procedure or Ampicillin 1 g iv just before pro-cedure followed by 500 mg 6 hrs later Ampicillin 1 g iv just before procedure followed by 500 mg 6 hrs
later and Cloxacillin 1 g iv and |
Patients allergic to
penicillin Erythromycin 1.5 g orally 1 hour before procedure folowed by 500 mg 6 hours later or Vancomycin 1 g iv just before procedure
Dosages for children: Clindamycin is preferred in patients on long term penicillin |
|
| Post splectomised children | Penicillin V 250 mg 12
hrly or Benzathine penicillin 1.2 mega monthly |
Pneumococcal vaccine should be given to the patient one month before splenectomy | |
| Close contacts of
meningococcal and haemophilus meningitis patients |
Adults (menin-gococcal
only) Rifampicin 600 mg 12 hrly for 2 days Children ( Men-ingococcal and haemophilus) Rifampicin |
In meningococcal meningitis treatment of the patient with penicillin may not reliably clear the nasopharynx of meningococci. A prophylactic course of rifampicin is advised for the convalescent patient before discharge back to the family circle. |
SURGICAL CHEMOPROPHYLAXIS
The use of antibiotic prophylaxis has been shown to prevent post-surgical wound
infections. When employed rationally significant reductions in morbidity and mortality and
savings in resources can be achieved. However when used excessively and in situations when
its benefit has not been proven, perioperative antibiotics can lead to unjustifiably high
costs of medical care. Single dose regimens or very short courses are unlikely to lead to
emergence of bacterial resistance but routine prolonged courses have been clearly
associated with increased rates of resistance.
Surgical operations can be divided into four broad categories :
Prophylaxis is generally recommended for clean-contaminated and contaminated operations. In clean operations prophylaxis maybe justified if the consequence of infection is very serious eg in cardiac operations and orthopaedic implants.
Another factor which should be considered in determining
probability of infection is the patient himself. Factors that reduce host defenses eg old
age, malignancy, malnutrition, steroid therapy, etc will increase the risk of infection.
In using antibiotics for surgical chemoprophylaxis the following principles should
be adhered to:
1. It is important to distinguish between prophylaxis and
treatment. Prophylaxis is given
when no infection exists previously. When an infection is already
present, even when
clinically not evident, treatment should be given.
2. Prophylaxis should be given only in certain conditions where the benefits clearly
outweigh the risks. The cost of prophylaxis should also be considered.
3. The antibiotic should be directed at the most likely contaminating organism for that
particular procedure. Choice of antibiotic will also depend on whether
the patient
has been in hospital for a prolonged period and the current pattern of
antibiotic
resistance in the hospital. In general the agent selected should (a) be
of low toxicity (b) have an
established safety record (c) reach a useful concentration in the
relevant tissues.
4. The route of administration, timing and duration of giving the antibiotic is planned to
achieve the maximum concentration of the antibiotic in the tissues
during and shortly
after the operation. Antibiotics are preferably given by the
intravenous route at the
time of induction of anaesthesia. In most instances a single
pre-operative dose would
suffice. Where surgery is prolonged additional intraoperative doses may
be given.
There is no evidence that there is any benefit in extending prophylaxis
beyond 24
hours after the operation.
5. Topical antibiotics are not recommended with the exception of opthalmic surgery
and cases of extensive skin loss.
6. Surgical chemoprophylactic regimens should be reviewed regularly and changes
made if necessary.
GUIDELINES FOR SURGICAL ANTIBIOTIC PROPHYLAXIS
| Operative procedure | 1st Choice antibiotic(s) | 2nd Choice antibiotic(s) |
| Caesarean section (anaerobes, streptococci, aerobic gram-negative bacilli) |
2o or 3o cephalosporin | 1. Gentamicin and
Metronidazole 2. Ampicillin and Metronidazole |
| Hysterectomy (anaerobes, streptococci) |
2o or 3o cephalosporin | Ampicillin and Metronidazole |
Operative procedure |
1st Choice antibiotic (s) |
2nd Choice antibiotic(s) |
| Cholecystectomy (open and
laparoscopic) (Aerobic gram-negative bacilli, enterococci, anaerobes) |
2o or 3o cephalosporin | 1. Beta-lactam/beta-lactamase
inhibitor 2. Gentamicin |
| Oesophageal/gastric
surgery (Aerobic gram-negative bacilli, streptococci) |
2o or 3o cephalosporin | Beta-lactam/betalactamase inhibitor |
| Colorectal surgery (Anaerobes, aerobic gram-negative bacilli, enterococci) |
2o or 3o cephalosporin and Metronidazole |
Gentamicin and Metronidazole |
| Appendicectomy (Anaerobes, aerobic gram-negative bacilli, enterococci) |
2o or 3o cephalosporin and Metronidazole |
Gentamicin and Metronidazole |
| Operative procedure | 1st Choice antibiotic(s) | 2nd Choice antibiotic(s) |
| Arterial replacement/ by-pass surgery | 2o cephalosporin | Cloxacillin and Gentamicin |
| Operative Procedure | 1st Choice antibiotic(s) | 2nd Choice antibiotic(s) |
| Valve replacement and coronary grafts | 2o or 3o cephalosporin |
| Operative Procedure | 1st Choice antibiotic(s) | 2nd Choice antibiotic(s) |
| Lobectomy and pneumonectomy | 2o or 3o cephalosporin |
| Operative Procedure | 1st Choice antibiotic(s) | 2nd Choice antibiotic(s) |
| Arthroplasty and joint
replacements (Staphylococci) |
Cloxacillin and Gentamicin | 2o cephalosporin |
| Open reduction of
fractures (Staphylococci) |
Cloxacillin and Gentamicin | 2o cephalosporin |
| Operative Procedure | 1st Choice antibiotic(s) | 2nd Choice antibiotic(s) |
| Major oral, head and neck
surgery (streptococci, anaerobes, aerobic gram-negative bacilli) |
2o or 3o cephalosporin and Metronidazole |
| Operative Procedure | 1st Choice antibiotic(s) | 2nd Choice antibiotic(s) |
| Craniotomy (Staphylococci) |
2o cephalosporin | Cloxacillin and Gentamicin |
| Shunt procedures (Staphylococci) |
2o cephalosporin | Cloxacillin and Gentamicin |
| Operative Procedure | 1st Choice antibiotic(s) | 2nd Choice antibiotic(s) |
| Stone surgery and
prostatectomy (Enterobacteriaceae) |
2o or 3o cephalosporin | Gentamicin |
Endoscopic procedures
Antibiotic prophylaxis for endoscopic procedures are given for 2 main reasons:
1) to prevent endocarditis (see table below for degree of risk)
2) to prevent infective complications
| Operative Procedure | 1st Choice antibiotic(s) | 2nd Choice antibiotic(s) |
| Hepatobiliary, pancreatic in
the presence of obstruction (Enterobacteriaceae) |
2o or 3o cephalosporin | Gentamicin |
| Cystoscopy, nephroscopy and
stents (Enterobacteriaceae) |
2o or 3o cephalosporin | Gentamicin |
| Arthroscopy (Staphylococci) |
2o cephalosporin | Cloxacillin and Gentamicin |
Estimated risk of endocarditis associated with
preexisting cardiac disorders.
(From New Engl J Med 1995, 323:39)
Relatively high risk |
Intermediate risk |
Very low or negligible risk |
| Prosthetic heart
valves Previous endocarditis Cyanotic congenital heart failure Patent ductus arteriosus Aortic regurgitation Aortic stenosis Mitral regurgitation Mitral stenosis and regurgitation Ventricular septal defect Coartation of the aorta Surgically repaired intracardiac lesions with residual haemodynamic abnormality |
Mitral valve prolapse with
regurgitation Pure mitral stenosis Tricuspid valve disease Pulmonary stenosis Asymmetric septal hypertrophy Bicuspid aortic valve or calcific aortic sclerosis with minimal haemodynamic abnormality Degenerative valvular disease in elderly patients Surgically repaired intracardiac lesions with no haemodynamic abnormality, less than 6 months after the operation |
Mitral valve prolapse without
regurgitation Trivial valvular regurgitation on echocardiography without structural abnormality Isolated atrial septal defect Arteriosclerotic plaques Coronary artery disease Cardiac pacemaker Surgically repaired intraccardiac lesions, with minimal or no haemodynamic abnormality, more than six months after operation |
Note : The following dosing guidelines are the usually recommended regimens. They may not apply to all patients nor to all infections. When in doubt always consult a specialist.
Antibiotic |
Usual oral regimen |
Usual parenteral regimen |
| Amphotericin B | 0.25 - 1.5 mg/kg/day | |
| Amikacin | 7.5 mg/kg 8 hrly | |
| Amoxycillin | 250 - 500 mg 8 hrly | |
| Amoxycillin-Clavulanate | 250 - 500 mg 8 hrly (based on amoxycillin) | |
| Ampicillin | 250 - 500 mg 6hrly | 1 - 2 g 6 hrly |
| Ampicillin-sulbactam (Sultamicillin) | 375 - 750 mg 12hrly | 1 - 2 g 6hrly or 8 hrly |
| Azithromycin | 500 mg dly | |
| Bacampicillin | 400 - 800 mg 12 hrly | |
| Carbenicillin | 500 mg - 1 g 6 hrly | 5 - 6 g 6 hrly |
| Cefoperazone | 1 - 2 g 8 - 12 hrly | |
| Cefotaxime | 1 - 2 g 8 - 12 hrly | |
| Ceftazidime | 1 - 2 g 8 - 12 hrly | |
| Ceftriaxone | 500 mg - 1 g 12 - 24 hrly | |
| Cefuroxime | 250 mg 12 hrly | 750 mg - 1.5 g 8 - 12 hrly |
| Cephalexin | 250 mg - 1 g 6 hrly | |
| Chloramphenicol | 250 - 750 mg 6 hrly | 250 mg - 1 g 6 hrly |
| Ciprofloxacin | 250 - 750 mg 12 hrly | 400 mg 12 hrly |
| Clarithromycin | 250 - 500 mg 12 hrly | |
| Clindamycin | 150 - 300 mg 6 hrly | 300 - 900 mg 6 - 8 hrly |
| Cloxacillin | 500 mg - 1 g 6 hrly | 1 - 2 g 6 hrly |
| Doxycycline | 100 mg 12 hrly | |
| Erythromycin | 250 - 500 mg 6 hrly | 1 g 6 hrly |
| Fluconazole | 100 - 200 mg per day | 100 - 200 mg per day |
| Flucytosine | 37.5 mg/kg 6 hrly | |
| Fusidic acid | 500 mg 8 hrly | 500 mg 8 hrly |
| Gentamicin | 1.5 - 2 mg/kg 8 hrly | |
| Imipenem/Cilastatin | 500 mg - 1 g 6hrly | |
| Itraconazole | 100 - 200 mg per day | |
| Kanamycin | 5 - 7.5 mg/kg 8 hrly | |
| Ketoconazole | 200 - 400 mg 12 - 24 hrly | |
| Metronidazole | 250 - 750 mg 8 hrly | 500 mg 8 hrly |
| Nalidixic acid | 1 g 6hrly | |
| Netilmicin | 1.5 - 2 mg/kg 8 hrly | |
| Nitrofurantoin | 50 mg - 100 mg 6 - 8 hrly | |
| Norfloxacin | 400 mg 12 hrly | |
| Nystatin | 0.5 - 1 million units 6 hrly | |
| Ofloxacin | 200 - 400 mg 12 hrly | |
| Pefloxacin | 200 - 400 mg 12 hrly | |
| Penicillin G (Benzylpeniciilin) | 1 - 4 mega 4 - 6 hrly | |
| Procaine penicillin | 0.6 - 1.2 mega 12 - 24 hrly | |
| Benzathine penicillin | 0.6 - 1.2 mega monthly |